Tumor regression induced by YM155, a novel, survivin suppressant, in human diffuse large B-cell lymphoma models

被引：0
|
作者：
Kaneko, Naoki [1 ]
Kita, Aya [1 ]
Nakahara, Takahito [1 ]
Nakata, Mari [1 ]
Koutoku, Hiroshi [1 ]
Sasamata, Masao [1 ]
机构：
[1] Astellas Pharma Inc, Appl Pharmacol Res Labs, Tsukuba, Ibaraki 3058585, Japan
来源：
JOURNAL OF PHARMACOLOGICAL SCIENCES | 2010年 / 112卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：260P / 260P
页数：1
相关论文
共 50 条
  • [41] Marked anti-tumour activity of the combination of YM155, a novel survivin suppressant, and platinum-based drugs
    T Iwasa
    I Okamoto
    K Takezawa
    K Yamanaka
    T Nakahara
    A Kita
    H Koutoku
    M Sasamata
    E Hatashita
    Y Yamada
    K Kuwata
    M Fukuoka
    K Nakagawa
    British Journal of Cancer, 2010, 103 : 36 - 42
  • [42] Marked anti-tumour activity of the combination of YM155, a novel survivin suppressant, and platinum-based drugs
    Iwasa, T.
    Okamoto, I.
    Takezawa, K.
    Yamanaka, K.
    Nakahara, T.
    Kita, A.
    Koutoku, H.
    Sasamata, M.
    Hatashita, E.
    Yamada, Y.
    Kuwata, K.
    Fukuoka, M.
    Nakagawa, K.
    BRITISH JOURNAL OF CANCER, 2010, 103 (01) : 36 - 42
  • [43] YM155, a selective survivin suppressant, inhibits tumor spread and prolongs survival in a spontaneous metastatic model of human triple negative breast cancer
    Yamanaka, Kentaro
    Nakata, Mari
    Kaneko, Naoki
    Fushiki, Hiroshi
    Kita, Aya
    Nakahara, Takahito
    Koutoku, Hiroshi
    Sasamata, Masao
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2011, 39 (03) : 569 - 575
  • [44] Survivin Inhibitor YM155 Induces Apoptosis and Inhibits Tumor Growth of Human Gastric Carcinoma
    Cheng, Xiaojiao
    Ding, Yanfei
    Zhu, Liming
    Qiao, MInmin
    Ye, Jing
    Jiang, Shihu R.
    Tu, Shuiping
    GASTROENTEROLOGY, 2013, 144 (05) : S168 - S168
  • [45] PLK1 and survivin in diffuse large B-cell lymphoma
    Schmidt, Mathias
    LEUKEMIA & LYMPHOMA, 2007, 48 (11) : 2089 - 2090
  • [46] Prognostic models for diffuse large B-cell lymphoma
    Conconi, A
    Zucca, E
    Roggero, E
    Bertoni, F
    Bernasconi, A
    Mingrone, W
    Pedrinis, E
    Cavalli, F
    HEMATOLOGICAL ONCOLOGY, 2000, 18 (02) : 61 - 73
  • [47] YM155, a Survivin Suppressant, Induces Cell Death Via Suppression Of c-Myc Expression In Multiple Myeloma Cells
    Ito, Shigeki
    Asahi, Maki
    Sasaki, Ryousei
    Oyake, Tatsuo
    Tamura, Hideto
    Ishida, Yoji
    BLOOD, 2013, 122 (21)
  • [48] Markedly additive antitumor activity with the combination of a selective survivin suppressant YM155 and alemtuzumab in adult T-cell leukemia
    Chen, Jing
    Pise-Masison, Cynthia A.
    Shih, Joanna H.
    Morris, John C.
    Janik, John E.
    Conlon, Kevin C.
    Keating, Anne
    Waldmann, Thomas A.
    BLOOD, 2013, 121 (11) : 2029 - 2037
  • [49] Schedule-dependent antitumor activity of YM155, a novel small molecule survivin suppressant, in experimental human hormone refractory prostate carcinoma xenograft
    Nakahara, T
    Takeuchi, M
    Kinoyama, I
    Minematsu, T
    Matsuhisa, A
    Kita, A
    Tominaga, F
    Yamanaka, K
    Sasamata, M
    ANNALS OF ONCOLOGY, 2006, 17 : 38 - 38
  • [50] Diffuse large B-cell lymphoma - Molecular heterogeneity of diffuse large B-cell lymphoma
    Gascoyne, RD
    HEMATOLOGY JOURNAL, 2004, 5 : S144 - S148
12345